Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J Dong

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Drug Intelligence & Clinical Pharmacy|January 1, 1986
The nonequivalence of levothyroxine productsB J Dong, V R Young, B Rapoport
Zhonghua Yi Xue Za Zhi|May 7, 2023
[Research on the legal regulation of experimental medicine in China]B J Dong, Y H Yan, F G He
The Journal of the American Board of Family Practice|July 8, 1999
Sulfadiazine-induced crystalluria and renal failure in a patient with AIDSB J Dong, R A Rodriguez, R H Goldschmidt
The Western Journal of Medicine|June 1, 1984
Maintenance requirements of L-thyroxine in the treatment of hypothyroidismW A Kehoe, B J Dong, F S Greenspan
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|August 1, 1985
[Piriformis syndrome and its operative treatment: an analysis of sixty cases]M Y Lu, B J Dong, X Y Ma
The Journal of the American Board of Family Practice|January 1, 1995
Current report--HIV. Antiretroviral strategies revisitedR H Goldschmidt, B J Dong, J J Legg
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 1, 1997
Pharmacist provision of preventive health care services in a hypertension clinicB J Dong, S A Echaves, R V Brody, et al.
The Journal of the American Board of Family Practice|June 6, 1998
Individualized strategies in the era of combination antiretroviral therapyR H Goldschmidt, K B Balano, J J Legg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1997
A 5-year retrospective review of adverse drug reactions and their risk factors in human immunodeficiency virus-infected patients who were receiving intravenous pentamidine therapy for Pneumocystis carinii pneumoniaJ G O'Brien, B J Dong, R L Coleman, et al.
The Journal of the American Board of Family Practice|October 1, 1990
Current report--HIV. AIDS at the crossroads: a report from the 1990 International Conference on AIDS--San FranciscoR H Goldschmidt, B J Dong, G W Saba, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Drug Intelligence & Clinical Pharmacy|January 1, 1986
The nonequivalence of levothyroxine productsB J Dong, V R Young, B Rapoport
Zhonghua Yi Xue Za Zhi|May 7, 2023
[Research on the legal regulation of experimental medicine in China]B J Dong, Y H Yan, F G He
The Journal of the American Board of Family Practice|July 8, 1999
Sulfadiazine-induced crystalluria and renal failure in a patient with AIDSB J Dong, R A Rodriguez, R H Goldschmidt
The Western Journal of Medicine|June 1, 1984
Maintenance requirements of L-thyroxine in the treatment of hypothyroidismW A Kehoe, B J Dong, F S Greenspan
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|August 1, 1985
[Piriformis syndrome and its operative treatment: an analysis of sixty cases]M Y Lu, B J Dong, X Y Ma
The Journal of the American Board of Family Practice|January 1, 1995
Current report--HIV. Antiretroviral strategies revisitedR H Goldschmidt, B J Dong, J J Legg
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 1, 1997
Pharmacist provision of preventive health care services in a hypertension clinicB J Dong, S A Echaves, R V Brody, et al.
The Journal of the American Board of Family Practice|June 6, 1998
Individualized strategies in the era of combination antiretroviral therapyR H Goldschmidt, K B Balano, J J Legg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1997
A 5-year retrospective review of adverse drug reactions and their risk factors in human immunodeficiency virus-infected patients who were receiving intravenous pentamidine therapy for Pneumocystis carinii pneumoniaJ G O'Brien, B J Dong, R L Coleman, et al.
The Journal of the American Board of Family Practice|October 1, 1990
Current report--HIV. AIDS at the crossroads: a report from the 1990 International Conference on AIDS--San FranciscoR H Goldschmidt, B J Dong, G W Saba, et al.
Pageof 4